OP-106 Horizon - Melflufen therapy for RRMM patients refractory to daratumumab and/or pomalidomide: Updated results and first report on PFS Meeting Abstract


Authors: Richardson, P.; Ocio, E.; Oriol, A.; Larocca, A.; Otero, P. R.; Moreb, J.; Blade, J.; Hassoun, H.; Cavo, M.; Alegre, A.; Mazumder, A.; Maisel, C.; Paner, A.; Gabrail, N.; Zonder, J. A.; Chauhan, D.; Harmenberg, J.; Thuresson, S.; Zubairand, H.; Mateos, M. V.
Abstract Title: OP-106 Horizon - Melflufen therapy for RRMM patients refractory to daratumumab and/or pomalidomide: Updated results and first report on PFS
Meeting Title: 60th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 132
Issue: Suppl. 1
Meeting Dates: 2018 Dec 1-4
Meeting Location: San Diego, CA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2018-11-29
Language: English
ACCESSION: WOS:000454837601309
PROVIDER: wos
Notes: Meeting Abstract: 600 -- Source: Wos
MSK Authors
  1. Hani Hassoun
    149 Hassoun